Exubera Partnership In Doubt: Pfizer, Sanofi In Litigation Over Inhaled Insulin
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer is seeking to enforce "change-in-control" provisions in the Exubera co-marketing agreement. Sanofi-Aventis says it "has no idea" if Pfizer's goal is to buy out the partnership or force a sale to Sanofi.